Francisco Javier Lopez-Tapia

This inventor holds 38 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 10 EPO patents, primarily in Bruton's Tyrosine Kinase. Top assignees: Hoffmann-La Roche Inc., Roche Palo Alto LLC, Syntex (u.s.a.) Inc.. Active years: 1999-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francisco Javier Lopez-Tapia. Retrieved from https://idiyas.com/inventor/francisco-javier-lopez-tapia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 38 (Patent Applications = 1)

% Patents Active = 13.2

CIPO Patents = 3

EPO Patents = 10 (Patent Applications = 17)

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 95(Granted Patents)

Location History:

Fremont, CA (US) (1999 - 2006)
Union City, CA (US) (2002 - 2010)
Mahwah, NJ (US) (2012 - 2014)
Ewa Beach, HI (US) (2016 - 2017)
Honolulu, HI (US) (2014 - 2021)

Company Filing History:

17 out of 5,027

Hoffmann-La Roche Inc.

Chugai Pharmaceutical Co.

patents

5. 1 out of 1

Ro&cacute;he Palo Alto LLC

patent

where one patent can have more than one assignee

Years Active: 1999-2021

Loading Chart...

Areas of Expertise:

Bruton's Tyrosine Kinase

P2X7 Modulators

Thiazole Derivatives

Dihydropyrimidone Amides

Aryl Amides

Alpha 1A/B Antagonists

Imidazoline Derivatives

IP Antagonists

Arylamine-Substituted Compounds

Aryl Carboxylic Acid

Tetrazole Derivatives

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11104668 - Inhibitors of bruton's tyrosine kinase (2021-08-31),

2. 10640491 - Inhibitors of bruton's tyrosine kinase (2020-05-05),

3. 10093657 - Inhibitors of bruton's tyrosine kinase (2018-10-09),

4. 9802920 - Inhibitors of bruton's tyrosine kinase (2017-10-31),

5. 9663494 - Inhibitors of bruton's tyrosine kinase (2017-05-30),

6. 9624201 - Inhibitors of bruton's tyrosine kinase (2017-04-18),

7. 9556150 - Inhibitors of bruton's tyrosine kinase (2017-01-31),

8. 9556147 - Inhibitors of bruton's tyrosine kinase (2017-01-31),

9. 9499548 - Inhibitors of bruton's tyrosine kinase (2016-11-22),

10. 9469644 - Inhibitors of Bruton's tyrosine kinase (2016-10-18),

11. 9458105 - Inhibitors of Bruton's tyrosine kinase (2016-10-04),

12. 9359345 - Thiazole derivatives as inhibitors of Bruton's tyrosine kinase (2016-06-07),

13. 8940741 - Inhibitors of bruton's tyrosine kinase (2015-01-27),

14. 8889682 - Inhibitors of bruton'S tyrosine kinase (2014-11-18),

15. 8871760 - [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators (2014-10-28),

Title: Francisco Javier Lopez-Tapia: Innovator from Honolulu

Introduction: Francisco Javier Lopez-Tapia is a renowned inventor based in Honolulu, Hawaii. He is known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Francisco Javier Lopez-Tapia holds several patents in the areas of renewable energy technologies, sustainable agriculture practices, and advanced medical devices. His recent patents focus on enhancing efficiency and sustainability in different industries.

Career Highlights: With a career spanning over two decades, Francisco Javier Lopez-Tapia has worked with leading research institutions and companies to develop cutting-edge solutions. His dedication to pushing the boundaries of technology has earned him recognition in the innovation community.

Collaborations: Throughout his career, Francisco Javier Lopez-Tapia has collaborated with top universities, research institutions, and industry experts to bring his ideas to life. His collaborative approach has led to successful projects that have made a significant impact on society.

Conclusion: Francisco Javier Lopez-Tapia's passion for innovation and his commitment to creating a better future through his inventions make him a standout figure in the world of inventors. His work continues to inspire the next generation of innovators to think creatively and push the limits of what is possible.

Profile summary based on public USPTO records.